Form 4: Immunovant CTO Sells Shares to Cover Tax Obligations Following RSU Vesting

Immunovant, Inc.'s Chief Technology Officer, Jay S. Stout, sold 1,519 shares of common stock on July 9, 2025, at a weighted average price of $17.24 per share, to satisfy tax withholding obligations related to RSU vesting.

Summary

• Jay S. Stout, Chief Technology Officer of Immunovant, Inc., sold 1,519 shares of common stock.
• The transaction occurred on July 9, 2025.
• The shares were sold at a weighted average price of $17.24 per share, with prices ranging from $17.00 to $17.50.
• The sale was non-discretionary and mandated by Immunovant to cover tax withholding obligations associated with the vesting of 3,436 restricted stock units (RSUs).
• These RSUs were part of a larger grant of 54,978 RSUs on April 2, 2024, with the specific 3,436 units vesting on July 2, 2025.
• Following the transaction, Jay S. Stout beneficially owns 207,724 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary 'sell to cover' for tax purposes, which is a routine event and does not indicate a change in management's confidence or company performance, thus resulting in a neutral sentiment.

Future Outlook

No forward-looking statements or guidance are provided in this document.

Management Comments

• The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

This Form 4 filing details a routine insider transaction, specifically a 'sell to cover' sale, which is a common practice across all industries for employees to satisfy tax obligations upon the vesting of equity awards. It does not reflect broader industry trends or specific competitive dynamics.

Comparison to Industry Standards

• Sell-to-cover transactions are a standard and widely adopted mechanism for managing tax liabilities associated with equity compensation vesting across publicly traded companies globally. This transaction aligns with typical corporate governance practices for equity award programs.

Related Party Transactions

• The sale of shares by Jay S. Stout, a Chief Technology Officer, to cover tax withholding obligations related to RSU vesting is a transaction between a company officer and the issuer, which is a standard form of related party dealing in the context of equity compensation.

Stakeholder Impact

• Shareholders: Minimal impact due to the small volume of shares sold and the non-discretionary nature of the transaction, which is a routine administrative event.
• Employees: The vesting of RSUs is a positive event for the employee (Jay S. Stout), representing a realization of equity compensation.

Key Dates

Keywords

Immunovant, IMVT, Form 4, SEC filing, insider transaction, stock sale, restricted stock units, RSU vesting, tax withholding, sell to cover, Jay S. Stout, Chief Technology Officer